Lanthanum carbonate impacts on calcification regulating factors in chronic kidney disease
Phase of Trial: Phase IV
Latest Information Update: 07 Feb 2019
Price : $35 *
At a glance
- Drugs Lanthanum carbonate (Primary) ; Calcium carbonate
- Indications Renal failure
- Focus Therapeutic Use
- Acronyms MBD-CRF
- 31 Jan 2019 Status changed from not yet recruiting to completed.
- 13 Apr 2017 Planned End Date changed from 30 Jun 2015 to 31 Dec 2018.
- 24 Jul 2014 New trial record